Clinical Trial Update: Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

View source ↗

Summary

A ClinicalTrials.gov entry describes a study on conversion or neoadjuvant therapy for hepatocellular carcinoma, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Status: RECRUITING